Celltrion Pharm achieves record Q1 revenue of 112.5 billion won, up 16% year-on-year, driven by strong growth in chemical and biosimilar divisions
#YonhapInfomax #CelltrionPharm #Q1Revenue #ChemicalDivision #BiosimilarDivision #OperatingProfit #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=63416
#YonhapInfomax #CelltrionPharm #Q1Revenue #ChemicalDivision #BiosimilarDivision #OperatingProfit #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=63416